The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore

被引:50
|
作者
Ceschi, M
Sun, CL
Van Den Berg, D
Koh, WP
Yu, MC
Probst-Hensch, N
机构
[1] Univ Zurich Hosp, Canc Registry & Mol Epidemiol, CH-8091 Zurich, Switzerland
[2] Natl Univ Singapore, Fac Med, Dept Community Occupat & Family Med, Singapore 117597, Singapore
[3] Univ So Calif, Keck Sch Med, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA
[4] Univ Minnesota, Ctr Canc, Minneapolis, MN 55455 USA
关键词
D O I
10.1093/carcin/bgi093
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cyclin D1 (CCND1), an intracellular cell-cycle regulatory protein with checkpoint function, can promote cell proliferation or induce growth arrest and apoptosis depending on the cellular context. We hypothesized that the direction of the association between the (CCND1) G870A-polymorphism and breast cancer risk may be modified by dietary and genetic factors influencing the oxidant-antioxidant balance, such as a dietary pattern with a high intake of n-6 fatty acids and a low intake of n-3 fatty acids, or a genetic profile that is deficient in glutathione S-transferases. We tested our hypothesis in a case-control study nested into the Singapore Chinese Health Study, a prospective investigation of diet and cancer in 63 000 Chinese men and women. Genomic DNA collected from 258 incident cases of breast cancer and 670 female cohort controls was examined for CCND1, GSTM1, GSTT1 and GSTP1 genes using fluorogenic 5'-nuclease assay. Unconditional logistic regression models were used to assess the effects with adjustment for potential confounders. All statistical tests were two-sided. The heterozygous CCND1 GA genotype significantly reduced the breast cancer risk in all subjects (OR = 0.67, 95% CI 0.45-0.99) when compared with the GG genotype. The association was restricted to women with a high (above median value) intake level of n-6 fatty acids (OR = 0.51, 95% CI 0.30-0.87), a low (below median value) intake level of the antagonistic marine n-3 fatty acids (OR = 0.54, 95% CI 0.32-0.93) or a total lack of the antioxidative GSTM1 (OR = 0.44, 95% CI 0.25-0.80) or GSTT1 genes (OR = 0.46, 95% CI 0.24-0.87). The effects were consistently stronger in cases with advanced disease. The AA genotype did not affect breast cancer risk. The results of this study are compatible with the hypothesis that the oxidant-antioxidant balance in cells is an important determinant of the direction of the cyclin D1 effect, leading either to cell proliferation or cell death.
引用
收藏
页码:1457 / 1464
页数:8
相关论文
共 50 条
  • [1] The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study
    Probst-Hensch, Nicole M.
    Sun, Can-Lan
    Van den Berg, David
    Ceschi, Michela
    Koh, Woon-Puay
    Yu, Mimi C.
    [J]. CARCINOGENESIS, 2006, 27 (12) : 2475 - 2482
  • [2] CCND1 G870A Polymorphism with Altered Cyclin D1 Transcripts Expression Is Associated with the Risk of Glioma in a Chinese Population
    Chen, Xiangmei
    Zhao, Tianshu
    Li, Li
    Xu, Chunhui
    Zhang, Xiaolei
    Tse, Vincent
    Zhang, Ting
    Liu, Xiaoqian
    Lu, Fengmin
    [J]. DNA AND CELL BIOLOGY, 2012, 31 (06) : 1107 - 1113
  • [3] A case-control study of cyclin D1 CCND1 870A→G polymorphism and bladder cancer
    Cortessis, VK
    Siegmund, K
    Xue, SY
    Ross, RK
    Yu, MC
    [J]. CARCINOGENESIS, 2003, 24 (10) : 1645 - 1650
  • [4] Association between cyclin D1 (CCND1) G870A polymorphism and gastric cancer risk: a meta-analysis
    Zhang, Yafei
    Zeng, Xianling
    Lu, Hongwei
    Ji, Hong
    Zhao, Enfa
    Li, Yiming
    [J]. ONCOTARGET, 2016, 7 (40) : 66109 - 66118
  • [5] The cyclin D1 (CCND1) G870A polymorphism and lung cancer susceptibility: a meta-analysis
    Zhou, Changxi
    An, Huaijie
    Hu, Mingdong
    Liu, Qinghui
    Geng, Peiliang
    Xu, Jiancheng
    Sun, Baojun
    Liu, Changting
    [J]. TUMOR BIOLOGY, 2013, 34 (06) : 3831 - 3837
  • [6] Influence of CCND1 G870A polymorphism on the risk of HBV-related HCC and cyclin D1 splicing variant expression in Chinese population
    Zeng, Zhenzhen
    Tu, Jing
    Cheng, Jin
    Yao, Mingjie
    Wu, Yali
    Huang, Xiangbo
    Xie, Xiaomeng
    Zhang, Xiaolei
    Lu, Fengmin
    Chen, Xiangmei
    [J]. TUMOR BIOLOGY, 2015, 36 (09) : 6891 - 6900
  • [7] Effect of cyclin D1 (CCND1) polymorphism on gastric premalignant condition
    Tahara, Tomomitsu
    Shibata, Tomoyuki
    Yamashita, Hiromi
    Hirata, Ichiro
    Arisawa, Tomiyasu
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2008, 46 (12) : 1696 - 1701
  • [8] Absence of association between cyclin D1 (CCND1) G870A polymorphism and age of onset in hereditary nonpolyposis colorectal cancer
    Krüger, S
    Engel, C
    Bier, A
    Mangold, E
    Pagenstecher, C
    Doeberitz, MV
    Holinski-Feder, E
    Moeslein, G
    Keller, G
    Kunstmann, E
    Friedl, W
    Plaschke, J
    Rüschoff, J
    Schackert, HK
    [J]. CANCER LETTERS, 2006, 236 (02) : 191 - 197
  • [9] ASSOCIATION between Cyclin D1 (CCND1) Polymorphism and Gastric Cancer Risk in Japanese Population
    Tahara, Tomomitsu
    Arisawa, Tomiyasu
    Shibata, Tomoyuki
    Yamashita, Hiromi
    Hirata, Ichiro
    [J]. HEPATO-GASTROENTEROLOGY, 2009, 56 (93) : 1232 - 1235
  • [10] The Cyclin D1 (CCND1) A870G polymorphism predicts clinical outcome to lapatinib and capecitabine in HER2-positive metastatic breast cancer
    LaBonte, M. J.
    Wilson, P. M.
    Yang, D.
    Zhang, W.
    Ladner, R. D.
    Ning, Y.
    Gerger, A.
    Bohanes, P. O.
    Benhaim, L.
    El-khoueiry, R.
    El-khoueiry, A.
    Lenz, H. -J.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 (06) : 1455 - 1464